BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, July 14, 2025
See today's BioWorld Asia
Home
» Sinovac COVID-19 vaccine gets approved in China; doors opening elsewhere
To read the full story,
subscribe
or
sign in
.
Sinovac COVID-19 vaccine gets approved in China; doors opening elsewhere
Feb. 9, 2021
By
David Ho
and
Gina Lee
HONG KONG – Sinovac Biotech Ltd.’s COVID-19 vaccine, Coronavac, received conditional approval for use by the general public from China’s National Medical Productions Administration (NMPA), two days after filing for conditional market authorization.
BioWorld Asia
Regulatory
Vaccine
China
NMPA